Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Exagen

Exagen
2002 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
XGN STOCK SYMBOL
1 INVESTMENTS
$17.97 SHARE PRICE (As of Friday Closing)
Description

Exagen Diagnostics Inc was incorporated under the laws of the state of New Mexico in 2002. The Company is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets four products under its Avise brand to provide an accurate, timely and differential diagnosis and to optimize the treatment of ARDs. It processed approximately 9,300 patient specimens for its diagnostic product line, Avise SLE. It markets and sells solutions to community rheumatologists.

Website
Formerly Known As
Exagen Diagnostics
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Discovery Tools (Healthcare)
Stock Exchange
NAS
Primary Office
  • 1261 Liberty Way
  • Suite C
  • Vista, CA 92081
  • United States

+1 (888) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Exagen’s full profile, request a free trial.

Exagen Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$11.54 - $21.41 $226M $17.54 -$47.71 78.3K 12.6M

Exagen Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
Revenue 38,000 38,000 32,440 26,807
EBITDA (4,467) (22,607)
Net Income (8,012) (25,631)
Total Assets 28,887 20,390
Total Debt 24,698 18,836
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Exagen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Exagen‘s full profile, request access.

Request full access to PitchBook

Exagen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Exagen‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Exagen Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
QuantuMDx Venture Capital-Backed Newcastle Upon Tyne, United Kingdom 00 000.00 0000000000 0 000.00
0000000000 0000000 Corporate Backed or Acquired Cambridge, MA 000 00000 00000000000
000000 00000000 Corporation Salt Lake City, UT 0000 00000 000000 - 000 00000
00000 0000 0000000 Private Equity-Backed Irving, TX 000 00000 000000000 00000
0000000 Formerly VC-backed San Diego, CA 00 00000 000000000 00000
To view this company’s complete list of competitors, request access »

Exagen Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 08-Oct-2010 000000000000000000 000 Diagnostic Equipment
To view this company’s complete investment and acquisition history, request access »

Exagen Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Exagen‘s full profile, request access.

Request full access to PitchBook

Exagen Executive Team (20)

Name Title Board
Seat
Contact
Info
Fortunato Rocca Chief Executive Officer & Board Member
Kamal Adawi Chief Financial Officer & Secretary
Thierry Dervieux Ph.D Chief Scientific Officer
Tom Macpherson National Sales Director
Derren Barken Ph.D Executive

10 Former Executives

You’re viewing 5 of 20 executives. Get the full list »

Exagen Board Members (18)

Name Representing Role Since Contact
Info
Brian Birk Sun Mountain Capital Chairman & Board Member 000 0000
Bruce Robertson Ph.D H.I.G. BioHealth Partners Board Member 000 0000
Chester Burrell Self Board Member 000 0000
Daniel Burrell JD Self Board Member 000 0000
Ebetuel Pallares Ph.D Cottonwood Technology Fund Board Member 000 0000

7 Former Board Members

You’re viewing 5 of 18 board members. Get the full list »